What is CYP2B6?
The CYP2B6 gene encodes an enzyme in the liver that plays a specialized role in processing a select but very important group of medications. This enzyme is unique because it is involved in both the breakdown of active substances and the activation of specific medications (such as certain forms of chemotherapy). Your CYP2B6 status is genetically determined; this means your personal profile remains the same throughout your life and is not influenced by factors that cause temporary changes in blood levels.
The gene determines whether your body processes medication at the intended speed. If this pace deviates, it has direct consequences for the effectiveness of your treatment and the risk of unwanted side effects.
Why test your CYP2B6 status?
Because the activity of the CYP2B6 enzyme varies significantly per person, a standard dose may be unsafe or insufficiently effective for you. Insight into your profile helps in making the right treatment choices:
- Risk of treatment failure (Prodrugs): Some medications, including certain chemotherapies, must be ‘converted’ by CYP2B6 to work. With slow enzyme activity, the medication does not become active enough, causing the treatment to lose its potency.
- Accumulation of side effects: For active medications broken down by this enzyme, delayed action can lead to excessively high concentrations in the blood, significantly increasing the risk of serious side effects.
- Rapid clearance: With an overactive enzyme, medication is removed from your system so quickly that a sufficiently high level is never reached to be effective.
Medications where CYP2B6 plays a role
This enzyme is of great importance in the metabolism of, among others, the following agents:
- Antidepressants & Smoking Cessation: e.g., Bupropion (Wellbutrin/Zyban).
- HIV medication: e.g., Efavirenz and Nevirapine.
- Chemotherapy: e.g., Cyclophosphamide and Ifosfamide.
- Pain management & Addiction care: e.g., Methadone and Ketamine.
- Anesthetics: e.g., Propofol.
Interpretation of your CYP2B6 status
Based on your DNA analysis, you are classified into one of four metabolism types. This provides immediate insight into how your body responds to the mentioned medications:
| Result | Interpretatie | Interpretation |
|---|---|---|
| PM | Poor Metabolizer (Non-expressor) | The enzyme is inactive. This is the case for most Europeans. You have an increased risk of side effects with standard doses of specific medications. |
| IM | Intermediate Metabolizer | The enzyme exhibits limited activity. Medication processing is slower than average, often requiring careful dosing. |
| NM | Normal Metabolizer (Expressor) | The enzyme is active and functioning normally. Certain medications (such as tacrolimus) are broken down more quickly, so a higher dose is often required for effectiveness. |
| UM | Ultrarapid Metabolizer | The enzyme works extremely quickly. Medication is removed from the body very quickly, which increases the risk of insufficient effectiveness of the therapy. |
Medical interpretation & advice
Your test results from Easly are cross-referenced with the official medication guidelines of the KNMP (G-Standard). This provides you, your pharmacist, and your doctor with a scientific foundation for a personalized treatment plan.
Important: Always use this result in consultation with your treating physician or pharmacist. Never adjust your dosage independently. Based on your profile, a doctor or pharmacist may decide to optimize the dose or switch to a medication that does not depend on this specific enzyme.
Don’t keep struggling with unexplained side effects.
Do you want to know if your symptoms can be explained by your DNA profile? Take the free Pharmacogenetic Quickscan (Only available in Dutch) and get immediate clarity on whether a test is right for you.
